Spesolimab Therapeutic Cheat Sheet
Generalized pustular psoriasis (GPP) is a rare, autoinflammatory condition, with acute, severe flares of diffuse sterile pustules and systemic symptoms that can be life-threatening. Historically, cyclosporine, methotrexate, retinoids, and biologics modulating the interleukin-17 (IL-17), IL-23, and tumor necrosis factor α pathways have been used off-label for management.1 Aberrant IL-36 signaling …
Generalized pustular psoriasis (GPP) is a rare, autoinflammatory condition, with acute, severe flares of diffuse sterile pustules and systemic symptoms that can be life-threatening. Historically, cyclosporine, methotrexate, retinoids, and biologics modulating the interleukin-17 (IL-17), IL-23, and tumor necrosis factor α pathways have been used off-label for management.1 Aberrant IL-36 signaling … 
Dr. Eliot Battle, co-chair of the Skin of Color Update conference and CEO/Founder of Cultura Dermatology & Plastic Surgery, has a distinguished history of establishing safe and effective laser techniques in patients with skin of color. During his recent lecture at the 2023 Skin of Color Update conference, he shared with the audience his personal pearls and suggestions for establishing a thrivi … 
In today’s environment, the increasing consolidation of medical practices, the cost to finance, and the burden of administrative oversight create a challenge to start and maintain your own dermatology practice. This is particularly true when trying to start an aesthetic practice or medical spa. Here, we will learn from Dr. Eliot Battle, Chief Executive Officer (CEO) and Co-Founder of Cultura Der … 
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. Dr. Alexis points out that acne is the most common dermatologic condition for which patients with skin of color seek a dermatologist’s care. Hear why it’s impor … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about why a "mean" approach is most effective when treating warts. Watc … 